Bernd Gerber

Summary

Affiliation: University of Rostock
Country: Germany

Publications

  1. ncbi request reprint Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany
    Breast Cancer Res Treat 95:199-209. 2006
  2. ncbi request reprint Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Germany
    J Clin Oncol 19:960-71. 2001
  3. ncbi request reprint Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology
    Bernd Gerber
    Department of Obstetrics and Gynecology, Klinikum Innenstadt, Ludwig Maximilians University, Munich, Germany
    Clin Cancer Res 12:1245-50. 2006
  4. ncbi request reprint [Gynecological and obstetric aspects of general practice]
    B Gerber
    Director Klinik und Poliklinik für Frauenheilkunde der Universität Rostock
    MMW Fortschr Med 148:23-7. 2006
  5. ncbi request reprint Controversies in preservation of ovary function and fertility in patients with breast cancer
    Bernd Gerber
    Department of Gynecology and Obstetrics, University of Rostock, Klinikum Südstadt Rostock, Südring 81, Rostock, Germany
    Breast Cancer Res Treat 108:1-7. 2008
  6. ncbi request reprint Effectiveness of Trastuzumab (Herceptin) in a patient with locally recurrent breast cancer after cardiac failure caused by severe cytotoxic pretreatment
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Germany
    Oncology 61:271-4. 2001
  7. doi request reprint Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?
    Bernd Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Suedring 81, Rostock, Germany
    Breast Cancer Res Treat 128:613-24. 2011
  8. ncbi request reprint Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding
    B Gerber
    Department of Obstetrics and Gynaecology, University of Rostock, Post Box 10 08 88, 18055, Rostock, Germany
    Eur J Cancer 37:64-71. 2001
  9. ncbi request reprint [Skin sparing mastectomy with autologous immediate reconstruction: oncological risks and aesthetic results]
    B Gerber
    Frauenklinik, Universitat Rostock
    Zentralbl Gynakol 122:476-82. 2000
  10. ncbi request reprint Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound
    B Gerber
    Department of Obstetrics and Gynecology, Department of Pathology, and Institute of Medical Informatics and Biometry, University of Rostock, Rostock, Germany
    J Clin Oncol 18:3464-70. 2000

Detail Information

Publications70

  1. ncbi request reprint Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany
    Breast Cancer Res Treat 95:199-209. 2006
    ..We conclude that available data on CAM modalities in the treatment of early-stage breast cancer does not support their application...
  2. ncbi request reprint Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Germany
    J Clin Oncol 19:960-71. 2001
    ..All were classified as distant metastases-free using conventional staging methods...
  3. ncbi request reprint Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology
    Bernd Gerber
    Department of Obstetrics and Gynecology, Klinikum Innenstadt, Ludwig Maximilians University, Munich, Germany
    Clin Cancer Res 12:1245-50. 2006
    ..To investigate the effect of switching from adjuvant tamoxifen to anastrozole (Arimidex) treatment in postmenopausal women with endocrine-responsive breast cancer and histologically proven tamoxifen-induced benign endometrial pathology...
  4. ncbi request reprint [Gynecological and obstetric aspects of general practice]
    B Gerber
    Director Klinik und Poliklinik für Frauenheilkunde der Universität Rostock
    MMW Fortschr Med 148:23-7. 2006
    ..Numerous preparations with differing actions and applications used in contraception or hormone therapy in the post-menopausal woman, require individual counseling by the gynecologist...
  5. ncbi request reprint Controversies in preservation of ovary function and fertility in patients with breast cancer
    Bernd Gerber
    Department of Gynecology and Obstetrics, University of Rostock, Klinikum Südstadt Rostock, Südring 81, Rostock, Germany
    Breast Cancer Res Treat 108:1-7. 2008
    ..Therefore it seems necessary to inform breast cancer patients about the possible negative effects of preservation of ovarian function...
  6. ncbi request reprint Effectiveness of Trastuzumab (Herceptin) in a patient with locally recurrent breast cancer after cardiac failure caused by severe cytotoxic pretreatment
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Germany
    Oncology 61:271-4. 2001
    ..We encourage other oncologists to offer trastuzumab also to severely cytotoxically pretreated patients with conditions after cardiac insufficiency or with locally advanced breast cancer...
  7. doi request reprint Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?
    Bernd Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Suedring 81, Rostock, Germany
    Breast Cancer Res Treat 128:613-24. 2011
    ..Nonetheless, a rational and evidence-based approach to the management of clinically and sonographically N0 patients with planned breast-conserving surgery and limited tumor size is needed now...
  8. ncbi request reprint Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding
    B Gerber
    Department of Obstetrics and Gynaecology, University of Rostock, Post Box 10 08 88, 18055, Rostock, Germany
    Eur J Cancer 37:64-71. 2001
    ..Moreover, patients who are at a high risk for EC tend to avoid TVS screening. Finally, endometrial screening often results in unnecessary operations, which are associated with increased morbidity and costs...
  9. ncbi request reprint [Skin sparing mastectomy with autologous immediate reconstruction: oncological risks and aesthetic results]
    B Gerber
    Frauenklinik, Universitat Rostock
    Zentralbl Gynakol 122:476-82. 2000
    ..Is the oncological safety of skin sparing mastectomy (SSM) with immediate autologous reconstruction and improved aesthetic results comparable to postoperative findings in patients treated with modified radical mastectomy (MRM)?..
  10. ncbi request reprint Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound
    B Gerber
    Department of Obstetrics and Gynecology, Department of Pathology, and Institute of Medical Informatics and Biometry, University of Rostock, Rostock, Germany
    J Clin Oncol 18:3464-70. 2000
    ..To study the value of transvaginal ultrasound (TVS) in endometrial screening of postmenopausal breast cancer patients treated with tamoxifen...
  11. doi request reprint The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study
    Bernd Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany
    Ann Surg 249:461-8. 2009
    ..To find out if skin sparing mastectomy (SSM) and nipple sparing mastectomy (NSM) with immediate autologous reconstruction as safe in oncological terms as modified radical mastectomy (MRM)...
  12. pmc Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life
    Bernd Gerber
    Universitätsfrauenklinik am Klinikum Südstadt der Hansestadt Rostock, Germany
    Dtsch Arztebl Int 107:85-91. 2010
    ..Recurrent breast cancer remains a challenge for interdisciplinary treatment even though new therapeutic options are available...
  13. ncbi request reprint Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial
    Sibylle Loibl
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590, Frankfurt am Main, Germany
    Ann Surg Oncol 13:1434-42. 2006
    ..Neoadjuvant chemotherapy can increase the rate of breast-conserving surgery in patients with operable breast cancer. However, uncertainty remains regarding surgical procedures and predictors for successful breast-conserving surgery...
  14. ncbi request reprint How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis
    Toralf Reimer
    Department of Obstetrics and Gynecology, University of Rostock, Klinikum Suedstadt, Suedring 81, 18059 Rostock, Germany
    Ann Surg Oncol 15:472-7. 2008
    ..In the era of potential avoidance of axillary surgery we evaluate the impact of pathologic nodal status for adjuvant treatment decisions...
  15. ncbi request reprint Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Brigitte Rack
    Department of Gynecology and Obstetrics, I Frauenklinik, Klinikum der Ludwig Maximilians Universitaet, Munich, Germany
    Breast Cancer Res Treat 82:83-92. 2003
    ..Persisting prognostic impact after relapse would identify lymph node status as a marker for tumor biology, in contrast to a simply time-dependent phenomenon...
  16. ncbi request reprint Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence
    Udo Jeschke
    Ludwig Maximilians University of Munich, Department of Obstetrics and Gynecology, 80337 Munich, Germany
    Anticancer Res 27:1969-74. 2007
    ....
  17. doi request reprint Breast reconstruction with a latissimus dorsi flap in a patient who had had her axillary lymph nodes irradiated in childhood
    Toralf Reimer
    Department of Obstetrics and Gynaecology, University of Rostock, Klinikum Suedstadt, Rostock, Germany
    Scand J Plast Reconstr Surg Hand Surg 42:48-50. 2008
    ..Twenty-two years later she developed a secondary breast carcinoma which was managed by skin-sparing mastectomy and immediate reconstruction with a pedicled latissimus dorsi flap...
  18. pmc Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis
    Claudia Röwer
    Proteome Center Rostock, University of Rostock, Rostock, Germany
    Int J Clin Exp Pathol 4:454-67. 2011
    ..Such comprehensive data sets are needed for both, pathway analyses and for "next generation clinical diagnostics" approaches...
  19. pmc Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure
    Bernd Gerber
    Department of Obstetrics and Gynecology, LMU Munich, Maistrasse 11, 80337 Munich, Germany
    Ann Surg 238:120-7. 2003
    ..Is skin-sparing mastectomy (SSM) with conservation of the Nipple-Areola Complex (NAC) and immediate autologous reconstruction as safe in oncologic terms as SSM with resection of the NAC as modified radical mastectomy (MRM)?..
  20. ncbi request reprint Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread
    Bernd Gerber
    Department of Obstetrics and Gynecology, Klinikum Innenstadt, Ludwig Maximilians University Munich, Munich, Germany
    Breast Cancer Res Treat 82:29-37. 2003
    ..Is a perioperative metastatic screening program indicated in patients presenting with primary operable breast cancer and no signs of distant metastases?..
  21. ncbi request reprint Pregnancy-associated breast cancer -- special features in diagnosis and treatment
    Wolfgang Janni
    Obstetrics and Gynecology Clinic and Polyclinic of Ludwig Maximilian University, Klinikum Innenstadt, Munchen, Germany
    Onkologie 29:107-12. 2006
    ..The following article summarizes the special features of the diagnosis and primary therapy of pregnancy-associated breast cancer with particular consideration of cytostatic therapy...
  22. doi request reprint Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma
    Claudia Röwer
    Proteome Center Rostock, Department for Proteome Research, Institute of Immunology, Medical Faculty, University of Rostock, Schillingallee 69, P O Box 100 888, Rostock 18055, Germany
    J Am Soc Mass Spectrom 22:440-56. 2011
    ....
  23. ncbi request reprint Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis
    Udo Jeschke
    I Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Munich, Germany
    Anticancer Res 25:1615-22. 2005
    ..In this study, we analysed the combined expression of SLeX, SLea, Cathepsin-D and E-cadherin in breast carcinoma in situ, invasive carcinomas without metastasis and invasive carcinomas with lymph node metastasis...
  24. doi request reprint The role of hydroxyethyl starch in preventing surgical-site infections and nipple necrosis in patients undergoing reduction mammaplasty: a prospective case-control study of 334 patients
    Max Dieterich
    Department of Obstetrics and Gynecology, Breast Unit, University of Rostock, Suedring 81, 18059, Rostock, Germany
    Aesthetic Plast Surg 37:554-60. 2013
    ..This study investigated the postoperative antiinflammatory influence of hydroxyethyl starch and its effect on surgical-site infections after breast reduction...
  25. ncbi request reprint Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases
    Wolfgang Janni
    Department of Gynecology and Obstetrics, University Hospital, Ludwig Maximilians University, Maistrasse 11, 80337, Munich, Germany
    J Cancer Res Clin Oncol 129:503-10. 2003
    ....
  26. doi request reprint Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results
    Hellen Knauerhase
    Department of Radiation Therapy, University of Rostock, Rostock, Germany
    Int J Radiat Oncol Biol Phys 72:1048-55. 2008
    ..To obtain long-term data on local tumor control after treatment of invasive breast cancer by breast-conserving surgery and adjuvant radiotherapy (RT), in consideration of the interstitial high-dose-rate boost technique...
  27. ncbi request reprint Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysis
    Sabine Semrau
    Department of Radiotherapy, University of Rostock, Rostock, Germany
    Strahlenther Onkol 182:596-603. 2006
    ..Data on concurrent radiochemotherapy (RCT) in these cases are scarce. The purpose of this study was to evaluate feasibility, toxicity and efficacy of local control of a radiotherapy combined with a chemotherapy containing a taxane...
  28. ncbi request reprint Pathologic nipple discharge: surgery is imperative in postmenopausal women
    Steffi Lau
    Department of Obstetrics and Gynecology, University of Rostock, Universitatsfrauenklinik, Suedring 81, 18059 Rostock, Germany
    Ann Surg Oncol 12:546-51. 2005
    ....
  29. doi request reprint Implant-based breast reconstruction using a titanium-coated polypropylene mesh (TiLOOP Bra): a multicenter study of 231 cases
    Max Dieterich
    Department of Obstetrics and Gynecology, Interdisciplinary Breast Center, University of Rostock, Rostock, Germany
    Plast Reconstr Surg 132:8e-19e. 2013
    ..The mesh was approved for implant-based breast reconstruction in Europe in 2008, but only limited clinical data are available...
  30. ncbi request reprint Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence
    Udo Jeschke
    Department of Obstetrics and Gynaecology, Ludwig Maximilians University of Munich, Maistrasse 11, 80337 Munich, Germany
    Oncol Rep 13:413-9. 2005
    ..In contrast, cases of breast cancer with metastatic infiltration and recurrence show weak expression of glycodelin. On the basis of these results, we speculate that glycodelin could be used as a prognostic marker for breast cancer...
  31. doi request reprint Invasive hydatidiform mole: immunohistochemical labelling of inhibin/activin subunits, Ki67, p53 and glycodelin A in a rare case
    Josef Makovitzky
    Department of Obstetrics and Gynaecology, University of Rostock, Rostock, Germany
    Acta Histochem 111:360-5. 2009
    ..Therefore, since the pathological diagnosis of an invasive mole is difficult, the immunohistochemical detection of inhibin/activin subunits, Ki67, p53 and glycodelin A might be additional useful tumour markers...
  32. doi request reprint Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly
    Toralf Reimer
    Department of Obstetrics and Gynecology, University of Rostock, Klinikum Suedstadt, Rostock, Germany
    Drugs Aging 27:791-800. 2010
    ..Future studies that include QOL measurements should also provide details on the data collection and quality control methodologies used...
  33. doi request reprint Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis
    Toralf Reimer
    University of Rostock, Department of Obstetrics and Gynecology, Rostock, Germany
    J Matern Fetal Neonatal Med 26:263-9. 2013
    ..To investigate the serum level distribution of angiogenic markers (PlGF, endoglin, sFlt-1) and acute-phase proteins (SAA, CRP) in patients with HELLP syndrome or preeclampsia (PE) including matched controls...
  34. ncbi request reprint Nutrition and lifestyle factors on the risk of developing breast cancer
    Bernd Gerber
    Department of Obstetrics and Gynaecology, University of Rostock, Germany
    Breast Cancer Res Treat 79:265-76. 2003
    ..A health lifestyle, consisting of 'healthy diet', physical activity, renunciation of stimulants, is recommended from childhood throughout life...
  35. ncbi request reprint Concurrent radiochemotherapy of locally recurrent or advanced sarcomas of the uterus
    Berith Kortmann
    Department of Radiotherapy, University of Rostock, Germany
    Strahlenther Onkol 182:318-24. 2006
    ..Uterine sarcomas are rare tumors. Until now, no data on the treatment of recurrent or advanced uterine sarcomas using concurrent radiochemotherapy (RCT) has been available...
  36. ncbi request reprint Transection of vaginal cuff is an independent prognostic factor in stage I endometrial cancer
    H Arndt-Miercke
    Department of Obstetrics and Gynecology, University of Rostock, Klinikum Suedstadt, Suedring 81, 18059 Rostock, Germany
    Eur J Surg Oncol 34:241-6. 2008
    ....
  37. doi request reprint Pain management after cesarean: a randomized controlled trial of oxycodone versus intravenous piritramide
    Max Dieterich
    Department of Obstetrics and Gynecology, University of Rostock, Südring 81, 18059 Rostock, Germany
    Arch Gynecol Obstet 286:859-65. 2012
    ..Secondary outcomes were additional pain medication, time to first mobilization, therapeutic side effects, postoperative restrictions, overall satisfaction and costs...
  38. doi request reprint Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue
    Claudia Röwer
    Proteome Center Rostock, University of Rostock, 18055, Rostock, Germany
    Anal Bioanal Chem 395:2443-56. 2009
    ....
  39. doi request reprint Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study
    Bernd Gerber
    University of Rostock, Rostock, Germany
    J Clin Oncol 29:2334-41. 2011
    ..We aimed to test the efficacy of ovarian function preservation with the LHRHa goserelin in patients with breast cancer...
  40. pmc Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer
    Toralf Reimer
    Department of Obstetrics and Gynaecology, University of Rostock, Faculty of Medicine, Germany
    Breast Cancer Res 4:R9. 2002
    ..The objective of the present study was to examine the prognostic and predictive significance of the apoptosis-related marker Fas ligand (FasL):Fas ratio in breast cancer...
  41. doi request reprint The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro
    Conrad Theil
    Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Rostock, Südring 81, 18059 Rostock, Germany
    Arch Gynecol Obstet 284:459-65. 2011
    ..In this study, the effects of the lignan secoisolariciresinol and the isoflavone glycosides and aglycones genistein, genistin, daidzein and daidzin were tested on MCF-7 and BT20 cells in vitro...
  42. ncbi request reprint Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis
    Christian Jackisch
    Department of Obstetrics and Gynecology, University of Marburg, Pilgrimstein 3, D 35037 Marburg, Germany
    Clin Breast Cancer 3:276-80. 2002
    ..The application of both schedules is safe and feasible in an outpatient setting. Although, results obtained from this interim analysis are encouraging, caution is recommended until the results obtained show statistical difference in pCR...
  43. doi request reprint Management of early invasive breast cancer in very young women (<35 years)
    Steffi Hartmann
    Department of Obstetrics and Gynecology, University of Rostock, Südring 81, Rostock, Germany
    Clin Breast Cancer 11:196-203. 2011
    ..To give an overview about current treatment recommendations and special problems concerning the management of women <35 years with early breast cancer...
  44. ncbi request reprint Breast reconstruction with latissimus dorsi flap: improved aesthetic results after transection of its humeral insertion
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Germany
    Plast Reconstr Surg 103:1876-81. 1999
    ..The additional transection of the tendinous humeral insertion of the latissimus dorsi muscle improves aesthetic results and avoids a displeasing bulge in the axilla when the latissimus dorsi flap is used for breast reconstruction...
  45. ncbi request reprint Human chorionic gonadotrophin-beta transcripts correlate with progesterone receptor values in breast carcinomas
    T Reimer
    Department of Obstetrics and Gynaecology, University of Rostock, Faculty of Medicine, Rostock, Germany
    J Mol Endocrinol 24:33-41. 2000
    ..The relationship with PgR expression may suggest that progestins regulate the expression of hCG in breast epithelial cells...
  46. ncbi request reprint Differential diagnosis of peri- and postmenopausal ovarian cysts
    T Reimer
    Department of Obstetrics and Gynecology, University of Rostock, Germany
    Maturitas 31:123-32. 1999
    ..To test the value of preoperative and intracystic parameters in the differential diagnosis of ovarian cysts...
  47. doi request reprint Two different entities of spontaneous ovarian hyperstimulation in a woman with FSH receptor mutation
    M Dieterich
    Department of Obstetrics and Gynecology, University of Rostock, Suedring 81, 18055 Rostock, Germany
    Reprod Biomed Online 20:751-8. 2010
    ..This report confirms for the first time the in-vitro findings in a single clinical case that TSH as well as HCG leads to spontaneous OHSS in patients with FSHR D567N mutation. Hypothyroidism has to be treated or ruled out...
  48. doi request reprint Fracture of maternal sternum during spontaneous delivery
    J Stubert
    Department of Obstetrics and Gynecology, University of Rostock, Germany
    Arch Gynecol Obstet 280:1007-9. 2009
    ..A possible promoting factor might be pregnancy-induced bone loss. Although there were clear symptoms, the diagnosis of the fracture was delayed by a week because nobody took account of such a possibility...
  49. ncbi request reprint [Rating of transvaginal sonography in the evaluation of postmenopausal bleeding]
    B Gerber
    Universitäts Frauenklinik Rostock
    Zentralbl Gynakol 121:143-8. 1999
    ..The purpose of this study was to evaluate transvaginal ultrasonography (TVS) in differential diagnosis of vaginal bleedings in postmenopausal patients...
  50. ncbi request reprint Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes
    T Reimer
    Department of Obstetrics and Gynaecology and Institute of Immunology, University of Rostock, Germany
    Mol Hum Reprod 8:674-80. 2002
    ..In the case of feto-maternal contribution of polymorphic genes to pre-eclampsia, expression analysis of placental tissue has lead to numerous target genes waiting for large scale genetic linkage analyses...
  51. doi request reprint Desmopressin-induced Moschcowitz-like syndrome after treatment of uterine atonic bleeding in a 28-year-old pregnant woman: case report and overview of the literature
    Max Dieterich
    Department of Obstetrics and Gynecology, Südstadt Hospital, University of Rostock, Germany
    Blood Coagul Fibrinolysis 22:749-51. 2011
    ..In conclusion, desmopressin should not be administered in pregnant patients owing to its potential risk of triggering the development of thrombotic-thrombocytopenic purpura...
  52. ncbi request reprint Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow
    C Schindlbeck
    I Frauenklinik, Klinikum Ludwig Maximilians University, Munich, Germany
    Breast Cancer Res Treat 87:65-74. 2004
    ..The direct identification of HER2 on ITC-BM is the aim of ongoing research, potentially synergizing the prognostic relevance of ITC-BM and the predictive value of the HER2 status...
  53. ncbi request reprint Prognostic value of Ca 125 levels during primary therapy
    Susanne Markmann
    Department of Obstetrics and Gynaecology in Klinikum Südstadt, University of Rostock, Südring 81, 18059 Rostock, Germany
    Anticancer Res 27:1837-9. 2007
    ..Complete cytoreductive surgery is the most important prognostic factor. We investigated the suitability of Ca 125 as a prognostic factor in patients with ovarian cancer at various...
  54. ncbi request reprint Expression pattern of progranulin in the human placenta and its effect on cell proliferation in the choriocarcinoma cell line BeWo
    Johannes Stubert
    Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany
    J Reprod Dev 57:229-35. 2011
    ..The observed effect of progranulin on cell proliferation in BeWo cells may indicate a growth stimulating effect also on the small part of proliferating extravillous trophoblast cells during placental development...
  55. doi request reprint Postoperative infections due to bladder catheters after anterior colporrhaphy: a prospective, randomized three-arm study
    Ute Kringel
    Department of Obstetrics and Gynaecology, University of Rostock, Rostock, Germany
    Int Urogynecol J 21:1499-504. 2010
    ..If IUCs have no higher rate of infections or complications compared to SUC for 96 h, the former could be considered sufficient...
  56. ncbi request reprint [Detection of atypical site of "sentinel lymph nodes" by lymph drainage scintigraphy in patients with breast carcinoma]
    A Krause
    Frauenklinik, Universitat Rostock
    Zentralbl Gynakol 122:514-8. 2000
    ..Sentinel lymph node (SLN) localization in breast cancer allows biopsy of directly tumor drained lymph nodes. The objective was to study the association of tumor and SLN localization...
  57. doi request reprint Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy
    Volker Briese
    Gynaecological University Hospital and Polyclinic, Clinical Centre Südstadt Rostock, Südring 81, 18059 Rostock, Germany
    Arch Gynecol Obstet 283:585-90. 2011
    ....
  58. ncbi request reprint Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients
    C Richter
    Department of Obstetrics and Gynecology, University of Rostock, Südring 81, 18059 Rostock, Germany
    Anticancer Res 27:2023-5. 2007
    ..Glycodelin A (GdA), also known as placental protein 14 (PP14), has been detected in endometrial, cervical and ovarian carcinoma cells. It is suspected to be a marker of human ovarian cancer tissues...
  59. ncbi request reprint Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole
    D U Richter
    Department of Obstetrics and Gynaecology, University of Rostock, Südring 81, 18059 Rostock, Germany
    Anticancer Res 27:2001-3. 2007
    ..Specific carrier proteins of the TF-antigen are the mucins, in particular Mucin 1. Here, we present our results of immunohistochemical identification of this carbohydrate antigen in human placenta...
  60. ncbi request reprint A pooled analysis of bone marrow micrometastasis in breast cancer
    Stephan Braun
    Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria
    N Engl J Med 353:793-802. 2005
    ..We assessed the prognostic significance of the presence of micrometastasis in the bone marrow at the time of diagnosis of breast cancer by means of a pooled analysis...
  61. ncbi request reprint Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases
    Naim Shabani
    I Department of Obstetrics and Gynaecology, Ludwig Maximilians University of Munich, Maistrasse 11, 80337 Munich, Germany
    Anticancer Res 25:1761-4. 2005
    ..Recently, glycodelin was demonstrated to be expressed in normal and cancerous human breast tissue...
  62. ncbi request reprint Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group
    Gunter von Minckwitz
    German Breast Group, Neu Isenburg Frankfurt, Germany
    J Clin Oncol 23:2676-85. 2005
    ..Dose-dense and sequential administration of cytotoxic drugs are current approaches to improve outcomes in patients with early-stage breast cancer...
  63. doi request reprint Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
    Gunter von Minckwitz
    German Breast Group, Frankfurt, Germany
    J Natl Cancer Inst 100:552-62. 2008
    ..The relationship between extended chemotherapy and pathological complete response at surgery was investigated in a clinical trial...
  64. ncbi request reprint CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)
    Gunter von Minckwitz
    German Breast Group, Schleussnerstrase 42, 63263 Neu Isenburg, Germany
    Eur J Cancer 42:1780-8. 2006
    ..79 (95% CI=0.54-1.14; P=0.19). It is concluded that medical ovarian ablation with goserelin represents a valid option for premenopausal patients with node-negative breast cancer...
  65. ncbi request reprint Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps
    Ioannis Mylonas
    First Department of Obstetrics and Gynaecology, Ludwig Maximilians University Munich, Maistrasse 11, 80337 Munich, Germany
    Arch Gynecol Obstet 272:59-66. 2005
    ..Therefore, the aims of this study were to determine the frequency and tissue distribution of INH-alpha, INH-betaA and INH-betaB in normal human endometrium and glandular-cystic endometrial polyps, and polyps caused by tamoxifen use...
  66. ncbi request reprint Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis
    Ioannis Mylonas
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, 80337 Munich, Germany
    Oncol Rep 13:81-8. 2005
    ..Therefore, inhibin/activin subunits might be useful prognostic markers for breast cancer...
  67. ncbi request reprint Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone
    Ioannis Mylonas
    Ludwig Maximilians University Munich, 1st Department of Obstetrics and Gynecology, 80337 Munich, Germany
    Anticancer Res 25:1719-23. 2005
    ....
  68. doi request reprint Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
    Gunter von Minckwitz
    German Breast Group, Frankfurt, Germany
    J Natl Cancer Inst 100:542-51. 2008
    ..We compared the response of nonresponding patients who continued the same treatment with that of patients who switched to a well-tolerated non-cross-resistant regimen...
  69. ncbi request reprint The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
    Wolfgang Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
    Cancer 103:884-91. 2005
    ..If the persistence of ITCs after adjuvant therapy confers a similar risk for recurrence, then it would be an indication to consider secondary adjuvant therapy...
  70. ncbi request reprint Unexpected metastatic lobular carcinoma of the breast with intraabdominal spread and subsequent port-site metastasis after diagnostic laparoscopy for exclusion of ovarian cancer
    Ioannis Mylonas
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Munich 80337, Germany
    Gynecol Oncol 95:405-8. 2004
    ..Although lobular carcinomas metastasize primarily to lymph nodes, bone, lung and liver, they can also spread to the gastrointestinal tract, peritoneum and gynecologic organs...